SCHEMBL21135587

SCHEMBL21135587

COc1cc(N2CCC(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.86
INSR P06213 16/20 0.86
IGF1R P08069 16/20 0.86
AURKA O14965 2/20 0.84
ROS1 P08922 2/20 0.84
EML4 Q9HC35 2/20 0.84
EGFR P00533 2/20 0.80
CHEK1 O14757 1/20 0.80
NUAK1 O60285 1/20 0.80
JAK2 O60674 1/20 0.80
STK10 O94804 1/20 0.80
PRKD3 O94806 1/20 0.80
SLC34A2 O95436 1/20 0.80
CHEK2 O96017 1/20 0.80
ABL1 P00519 1/20 0.80
CD74 P04233 1/20 0.80
ERBB2 P04626 1/20 0.80
LCK P06239 1/20 0.80
FYN P06241 1/20 0.80
FES P07332 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15217786 0.95 INSR (0.88) ALKINSRIGF1RAURKAROS1
SCHEMBL11916574 0.93 ALK (0.86) ALKINSRIGF1RAURKAROS1
SCHEMBL21133486 0.93 ALK (0.85) ALKINSRIGF1RAURKAROS1
SCHEMBL29618196 0.93 ALK (0.85) ALKINSRIGF1RAURKAROS1
SCHEMBL11916602 0.93 ALK (0.85) ALKINSRIGF1RAURKAROS1
SCHEMBL11916477 0.93 ALK (1.00) ALKINSRIGF1RAURKAROS1
SCHEMBL22493313 0.92 ALK (0.84) ALKINSRIGF1RAURKAROS1
SCHEMBL30090750 0.92 ALK (0.84) ALKINSRIGF1RAURKAROS1
SCHEMBL15498495 0.92 ALK (0.84) ALKINSRIGF1RAURKAROS1
SCHEMBL11916595 0.92 ALK (0.86) ALKINSRIGF1RAURKAROS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019113071-A1 COMPOSITIONS AND METHODS FOR TREATING ALK-MEDIATED CANCER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2019-06-13 WO disclosed